Overview

Datavant specializes in health data technology, focusing on the secure exchange of patient information while maintaining privacy. The company's main product is software that de-identifies patient health data, removing personal identifiers and linking records from various sources. This allows healthcare providers, researchers, and other stakeholders to share and access health data securely, which is crucial for research and public health initiatives. For instance, during the COVID-19 pandemic, Datavant's technology helped connect different datasets to analyze the virus's effects on populations. The company operates on a subscription-based model, charging clients for access to its software, which can be tailored to their needs. Datavant stands out in the health data infrastructure market by addressing the growing demand for data interoperability and privacy, making it a vital resource for hospitals, research institutions, and pharmaceutical companies.

Simplify's Take

What believers are saying

• Increased demand for RWD insights drives partnerships enhancing data analysis capabilities.
• New R&D center in Galway signifies commitment to innovation and European expansion.
• Datavant's Clinical Insights Platform advances data intelligence for payers and providers.

What critics are saying

• Phishing attacks threaten Datavant's data security, as shown by a recent breach.
• Rapid expansion may strain resources and lead to integration challenges.
• Aggressive M&A strategy could result in integration risks and cultural clashes.

What makes Datavant unique

• Datavant's software de-identifies and links patient data securely across sources.
• The company has a vast network of over 70,000 hospitals and clinics.
• Datavant's SaaS model provides customizable solutions for diverse healthcare clients.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$80.5M

Above

Industry Average

Funded Over

2 Rounds

Notable Investors:

Founders FundSoftBank

Notable Investors:

Founders FundSoftBank

$40,000,000

Series B

Oct 2020

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Above Average

Industry standards

Ind Avg. $35M

$4M

$30M

$40M

$45M

$65M

$100M

View all funding stages